Piperacillin Sodium + Tazobactam Sodium

Piptaz®

Prescription Drug

Indications

For the treatment of the following moderate to severe infections caused by piperacillin-resistant, piperacillin/tazobactam-susceptible, and β-lactamase producing strains of susceptible microorganisms:

Adults and Adolescents

• Lower respiratory tract infections including severe community-acquired pneumonia and healthcare-associated pneumonia

  (Note:Healthcare-associated pneumonia caused by Pseudomonas aeruginosa should be treated in combination with an aminoglycoside)

• Uncomplicated and complicated skin and skin structure infections including cellulitis, cutaneous abscesses, and acute ischemic/diabetic foot infections
• Intraabdominal infections including appendicitis (complicated by rupture and abscess) and peritonitis
• Complicated and uncomplicated urinary tract infections
• Gynecologic infections including postpartum endometritis or pelvic inflammatory disease
• Bone and joint infections
• Bacterial sepsis
• Bacterial infections in neutropenic patients

  (Note: Full therapeutic doses of piperacillin/tazobactam plus an aminoglycoside should be used)

• Polymicrobic infections including those where aerobic and anaerobic organisms are suspected (intra-abdominal, skin and skin structure, upper and lower respiratory tract, gynecological).

Children

• Complicated intra-abdominal infections in children ≥ 2 months old
• Bacterial infections in febrile neutropenic children 2 to 12 years old

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.